| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1e94a8ff5bf244e45b630d5198e4334 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_022f1ce634bee5bfa3a07da725ce4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e3df10dd5d1c340bd06c3c36f51fa46 |
| publicationDate |
2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016136833-A1 |
| titleOfInvention |
Oral composition |
| abstract |
[Problem] The purpose of the present invention is to provide an oral composition that is easily ingested while having the effect of improving vascular endothelial function. [Solution] This oral composition comprises (a) geniposidic acid, (b) asperuloside, and (c) chlorogenic acid, the oral composition including 50-450 mg of said component (a) and 10-300 mg of said component (b) in a daily dosage, and 0.4-2 parts by weight of said component (a) and 0.2-2 parts by weight of said component (b) per 1 part by weight of said component (c). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I747945-B |
| priorityDate |
2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |